PT-141
10mg/vial
Melanocortin receptor agonist (MC3R/MC4R) studied for CNS-mediated arousal and sexual health pathway research.
Price per vial
$99.99
10mg/vial
Concentration
10mg/vial
Warehouse
US Domestic
Product Description
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. Unlike vascular-acting compounds, PT-141 acts centrally through MC3R and MC4R in the hypothalamus, making it a unique research tool for CNS-mediated arousal pathways.
Research Overview
PT-141 activates melanocortin receptors in the central nervous system, particularly the paraventricular nucleus of the hypothalamus, to initiate dopaminergic signaling pathways associated with sexual arousal behavior in research models. Studies have examined its mechanism of action in both male and female subjects, its dose-response profile, and its interaction with dopamine and oxytocin systems. Its CNS-first mechanism distinguishes it from PDE5 inhibitors and peripheral vasodilators. For laboratory research use only.
Research Applications
Research Use Only
This product is intended solely for laboratory research and analytical purposes. Not for human consumption or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA.